abstract |
The present invention provides an anti-SAR-COV-2 antibody, or an antigen-binding fragment thereof, and an application thereof, having a heavy chain complementary determining region as shown in SEQ ID Nos: 1-3, and a light chain complementary determining region as shown in SEQ ID Nos: 4-6. The antibody of the present invention is a humanized antibody, and has a low side effect, and high affinity and specificity. |